1.01k likes | 1.22k Views
Epidemiology and Oncology Translational Research in Clinical Oncology October 15, 2012 Neil Caporaso , MD Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute.
E N D
Epidemiology and OncologyTranslational Research in Clinical OncologyOctober 15, 2012Neil Caporaso, MDGenetic Epidemiology Branch,Division of Cancer Epidemiology and Genetics, National Cancer Institute
NIHNational Cancer Institute Division of Cancer Epidemiology and Genetics Genetic Epidemiology Branch National Institute of Health Includes many institutes…. We are INTRAMURAL ~ 85% $$ are extramural Cancer ETIOLOGY Other Branches focus on Nutrition, Hormones, Infection, Occupation, Statistics, Radiation
A Population Perspective on Cancer1. Introductory concepts2. Tools Epidemiologists use 3. Accomplishments of Epidemiology4. Challenges of Epidemiology5. Futures of Epidemiology
A Population Perspective on Cancer1. Introductory concepts2. Tools Epidemiologists use 3. Accomplishments of Epidemiology4. Challenges of Epidemiology5. Futures of Epidemiology
Domain of epidemiologyEpidemiology = causes of health and disease in human populations = epi (upon) + demos (the people) + logia (talk about)An OBSERVATIONAL science (like astronomy, evolutionary biology)Contrast with experimentalInvestigator does NOT get to pick who is exposed or unexposed Free-living people make choices about participating…possible BIASStudy of individuals with and without disease (contrast with Clinical Research)
What are the goals of epidemiology ?1. Identify the causes of cancer2. Quantify risks3. Identify risk groups4. Understand mechanisms5. Public health and health services6. Identify syndromes
Observational vs. ExperimentalEpidemiologists are ethically prohibited fromdoing experiments on people So, we observe large populations and seehow their outcomes relate to what people do (i.e., smoke, drink, eat, etc.)The weakness of the ‘observational’ argument was used by tobacco companiesto deny evidence linking cigarettes and cancer……
Epidemiologists emphasize preventionRationale:Effective (think polio, smallpox, smoking cessation, clean water, HPV…)Cheap (compared to late stage interventions)Public health orientationEliminate disease at the sourceDownsidesOften requires time to demonstrate effectiveness Less dramatic than treatmentHarder to see all the disease you have preventedLess positive political impactFewer Nobel PrizesPrimary = directed to susceptibility stageExample: Needle exchange to prevent AIDS, HPV vaccineSecondary = directed to subclinical stageExample: Screen for cervical cancer with Pap SmearTertiary = directed to clinical stage
Epidemiologists worry about biasBias= systematic deviation from truthIf the participation rate in a study is lowThe study subjects may not be REPRESENTATIVE of the target populationsand the worry is the study results may not be GENERALIZABLE to the general populationSelection Bias = subjects in the study are ‘selected’ and therefore nonrepresentative
Pilot studies: participation rate 30% participate in phone survey.49% participated in Invitation letter, Follow-up by phone, In hospital, Advertisements, Cash award, Physicians’ letter and Home/hospital 73% participate in New interviewers, Physicians’ call, Gas coupon, TV ads, New invitation letter, Mayor’s letter and Toll-free phone lineTotal number of subjects in pilot investigations: 156 Cases - 212 Controls 30% 73% 49%
Epidemiologists worry about controlsDownsidesOften requires time to demonstrate effectiveness Less dramatic than treatmentHarder to see all the disease you have preventedLess positive political impactFewer Nobel PrizesPrimary = directed to susceptibility stageExample: Needle exchange to prevent AIDS, HPV vaccineSecondary = directed to subclinical stageExample: Screen for cervical cancer with Pap SmearTertiary = directed to clinical stageExample: Treat diabetic retinopathy to prevent blindness
Why Population Controls? Gold standardRepresentative of the population from which cases deriveCan calculate absolute ratesReduces selection biasIMPLIESDefined population in time and spaceSpecified eligibility and exclusion criteriaDefined and high response rate
Epidemiologist as consultantQuestions the consulting epidemiologist will ask:Your study design is…?Your controls came from….?Did you collect key covariate data?Did you consider bias, confounding?What was the original hypothesis? (data dredging)Are you underpowered?Did you validate your marker?Epidemiologist is helpful when a question involves the population (as opposed to an individual, organ, cell, etc.)
The most common question epidemiologists get!Can you explain why…………..My grandmother smoked all her life. she drank heavily, her exercise was the TV remote,she never used a seat belt, she had bacon and buttered toast for breakfast…She drank shots on her 90th birthdayAnd she outlived all her doctors….. The race is not to the swift or the battle to the strong, nor does food come to the wise or wealth to the brilliant or favor to the learned; but time and chance happen to them all. (Ecclesiastes)Deterministic vs. Probabilistic
A Population Perspective on CancerIntroductory ConceptsTools Epidemiologists’ UseAccomplishments of EpidemiologyChallenges of EpidemiologyFutures for Epidemiology
GIS Geographic patterns of disease and exposure via satellite. Examples, used to estimate nitrate, pesticide levels
SEER Surveillance, Epidemiology, and End Results (SEER) Program26% of US populationincidence and survival, patient demographics, primary tumor site, tumor morphology and stage at diagnosis, first course of treatment, and follow-up for vital status comprehensive source of population-based information
Cancer Incidence Rates*, All Sites Combined, All Races, 1975-2000 Rate Per 100,000 Men Both Sexes Women
Men cancer rates 75% increase due to PSA screening
Cancer Incidence Rates* for Women, US, 1975-2000 Rate Per 100,000 Breast Colon & rectum Lung Uterine corpus Ovary *Age-adjusted to the 1970 US standard population. Source: Surveillance, Epidemiology, and End Results Program, 1973-1998, Division of Cancer Control and Population Sciences, National Cancer Institute, 2001.
Cancer death rates Why are cancer death rates leveling off?
Lung cancer death rates …..because the most common cause of cancer death is declining……
Childhood Cancers (< 14 ys)Incidence 8,600 new cases/yr 12,400 (0 – 19 ys) Mortality 1,500 deaths/yr 2,300 (0 – 19 ys) rates 50% since 1973 Etiology -- poorly understood
How do you prove a cause?1. It should confer high risk2. It should be consistent3. Dose response 4. Cause occurs first5. Biology makes sense
A Population Perspective on CancerIntroductory ConceptsTools Epidemiologists’ UseAccomplishments of EpidemiologyChallenges of EpidemiologyFutures for Epidemiology
Accomplishments (highly selected!)Identification of the Specific Causes of cancerRole as advocates of public healthRole as advocates of preventionIdentification of tobacco as causal factor for lung cancerRole of secondary tobacco smokeRole in the molecular redefinition of cancer
What are the general risk factors for cancer?Increasing ageEnvironmental factorsGenetic factorsCombinations of the above!
Causes of Cancer Deaths* Environmental pollution, Infectious agents, Lifestyle, Alcohol use, Occupational factors, Medicine, Radiation, Genetic susceptibility, other & unknown causes Tobacco ~30-35% Diet ~ 30-35% Other* ~30-35%
Most Cancer is due to the EnvironmentDramatic differences in cancer rates by geography and over time areonly compatible with extrinsic environmental causesEstablished by a vast body of descriptive, ecological, and analytical epidemiology
International Variation in Cancer RatesType of cancer H/L highest lowestMelanoma 155 Australia JapanNasopharynx 100 Hong Kong UKProstate 70 US (Blacks) ChinaLiver 50 China CanadaCervix 28 Brazil IsraelStomach 22 Japan KuwaitLung 19 US (Blacks) IndiaColon 19 US (Whites) IndiaBladder 16 Switzerland IndiaPancreas 11 US (Blacks) IndiaOvary 8 Maori (NZ) KuwaitBreast 7 Hawaii IsraelLeukemia 5 Canada India
Lung cancer mortality rate in Xuan Wei is among the highest in China County-specific female lung cancer mortality rates (per 100,000, 1973-75)
Copper smelter, Montana Copper Smelter, Montana
Tobacco and public health major cause of preventable morbidity & mortality 1/5 US deaths (450,000 USA, 3M world/y) 10 million tobacco deaths/yr (2030, WHO) 30% of all cancer, 8 sites, all difficult to treat tobacco related disease costs Medicare/ Medicaid > $10B/yr each In spite of widespread knowledge of the health consequences of smoking - rates in US adolescents are stable or increasing - declines in adults- leveled off - individual smoking cessation difficult
Per-Capita Consumption of Different Forms of Tobacco in The U.S. 1880-2003 Data Source USDA